Risa Labs
Founded 2024 · 213 employees on LinkedIn · 7 known investors
Risa Labs provides automated prior authorization and revenue-cycle workflows for oncology practices, handling Part B and Part D drug authorizations, eligibility and benefit verification, claims status tracking, and denial management. Its platform integrates with EHRs and payer portals, APIs, and e-fax to execute payer-related administrative tasks with configurable, rules-driven workflows.
Investors · 7
Better CapitalSanta Clara · $5K – $100K
Cencora VenturesSan Francisco · $1M – $10M
Oncology VenturesNew Yorkvia Ben Freeberg · inferred
Optum VenturesBoston
Z21 VenturesSan Francisco Bay Area · $500K – $1M
.png)
General Catalystreported · 2 sourcesSan Francisco · $30M
Also in the syndicate · 1
Odd Bird VC
Funding
SEC filings, press & company announcements- Undisclosed amountSeries AJan 2026Source ↗
- Undisclosed amountseed fundingApr 2025
General Catalyst, Odd Bird VC, Oncology Ventures, z21 Ventures
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Risa Labs do?
- Risa Labs provides automated prior authorization and revenue-cycle workflows for oncology practices, handling Part B and Part D drug authorizations, eligibility and benefit verification, claims status tracking, and denial management. Its platform integrates with EHRs and payer portals, APIs, and e-fax to execute payer-related administrative tasks with configurable, rules-driven workflows.
- Who are Risa Labs's investors?
- Risa Labs's investors include Better Capital, Cencora Ventures, Oncology Ventures, Optum Ventures, Z21 Ventures, General Catalyst.